Allegro Microsystems (ALGM) director receives grant of 1,094 RSUs
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Willett Robert reported acquisition or exercise transactions in this Form 4 filing.
ALLEGRO MICROSYSTEMS, INC. director Robert Willett received an equity grant of 1,094 shares of common stock in the form of Restricted Stock Units (RSUs). The award was granted at no cash cost per share and increases his direct holdings to 1,094 shares. Each RSU represents a contingent right to receive one share of common stock, and the RSUs will vest on the date of the next annual meeting following the grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Willett Robert
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,094 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 1,094 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
RSUs granted: 1,094 shares
Grant price per share: $0.00 per share
Shares held after grant: 1,094 shares
3 metrics
RSUs granted
1,094 shares
Equity award to director Robert Willett
Grant price per share
$0.00 per share
Stated price for RSU award
Shares held after grant
1,094 shares
Director’s direct ownership following RSU award
Key Terms
Restricted Stock Units ("RSUs"), contingent right, annual meeting
3 terms
Restricted Stock Units ("RSUs") financial
"Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
contingent right financial
"Each RSU represents a contingent right to receive one share of common stock."
annual meeting financial
"The RSUs will vest on the date of the next annual meeting following the grant date."
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
FAQ
What insider transaction did ALGM director Robert Willett report?
Robert Willett reported an equity grant of 1,094 Restricted Stock Units. These RSUs represent a contingent right to receive 1,094 shares of Allegro Microsystems common stock, increasing his direct holdings to 1,094 shares after the award.
At what price were the ALGM Restricted Stock Units granted?
The 1,094 Restricted Stock Units were granted at a stated price of $0.00 per share. This indicates a compensation award rather than a market purchase, consistent with typical director equity grants from the company.
When will Robert Willett’s ALGM RSUs vest?
The RSUs will vest on the date of the next annual meeting following the grant date. Vesting at the next annual meeting aligns the award with the company’s governance calendar and encourages service through that meeting date.
What does each ALGM RSU granted to the director represent?
Each Restricted Stock Unit represents a contingent right to receive one share of Allegro Microsystems common stock. The shares are delivered only upon vesting, which is scheduled for the date of the next annual meeting after the grant.
Is this ALGM Form 4 transaction a market purchase or a compensation award?
This transaction is a compensation award, not a market purchase. The Form 4 uses code “A” for a grant or award, with 1,094 RSUs issued at $0.00 per share as equity-based director compensation.